person · Reporting owner
Consonance Capital Opportunity Fund Management LP
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Surrozen, Inc./DECHFW · Entity 6092 | Director · 10% owner | November 23, 2020 | December 04, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Surrozen, Inc./DE
Report date November 23, 2020 · Filed December 04, 2020
Jointly reported with BLUTT MITCHELL J MD, Consonance Capital Management LP, Consonance Capman GP, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Ordinary SharesSEC Table I · non-derivative | IndirectBy Consonance Capital Master Account, LP | 500,000 |
Reported balance
After 2020-11-23 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-11-23 · Purchase · Acquired 500,000 · Balance 500,000 F1: Represents part of units of Consonance-HFW Acquisition Corp. (the "Issuer") purchased in the Issuer's initial public offering for $10 per unit. Each unit consists of one Class A ordinary share ("Class A Share") of the Issuer and one-third of one warrant ("Warrant"), with each whole Warrant entitling the holder to purchase one Class A Share at $11.50 per share. The Warrants will not become exercisable until the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering. The Warrants are not being reported on this Form 4 because they cannot be exercised until the satisfaction of material conditions outside the control of the Reporting Persons. F2: Consonance Capital Management LP ("Consonance Management") is an indirect beneficial owner of the Class A Shares held by Consonance Capital Master Account, LP (the "Master Account"). Consonance Management is the investment adviser of the Master Account, and pursuant to an investment advisory agreement, Consonance Management exercises voting and investment power over the securities of the Issuer held by the Master Account. Consonance Capman GP LLC ("Capman") is the general partner of Consonance Management. Consonance Management receives an asset-based fee, but has no pecuniary interest. Mitchell Blutt is the manager and member of Capman and has a pecuniary interest in the shares held by the Master Account as the manager and member of the general partner of the Master Account and thereby is entitled to a portion of the profits allocation. F3: (Continued from footnote 2) Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of such securities of the Issuer except to the extent of their pecuniary interest therein. |
| Class A Ordinary SharesSEC Table I · non-derivative | IndirectBy Consonance Capital Opportunity Master Fund, LP | 371,100 |
Reported balance
After 2020-11-23 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2020-11-23 · Purchase · Acquired 371,100 · Balance 371,100 F1: Represents part of units of Consonance-HFW Acquisition Corp. (the "Issuer") purchased in the Issuer's initial public offering for $10 per unit. Each unit consists of one Class A ordinary share ("Class A Share") of the Issuer and one-third of one warrant ("Warrant"), with each whole Warrant entitling the holder to purchase one Class A Share at $11.50 per share. The Warrants will not become exercisable until the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering. The Warrants are not being reported on this Form 4 because they cannot be exercised until the satisfaction of material conditions outside the control of the Reporting Persons. F4: Consonance Management is an indirect beneficial owner of the Class A Shares held by Consonance Capital Opportunity Master Fund, LP ("Consonance Opportunity Master"). Consonance Management is the investment adviser of Consonance Opportunity Master, and pursuant to an investment advisory agreement, Consonance Management exercises voting and investment power over the securities of the Issuer held by Consonance Opportunity Master. Capman is the general partner of Consonance Management. Consonance Management receives an asset-based fee, but has no pecuniary interest. Mitchell Blutt is the manager and member of Capman and has a pecuniary interest in the shares held by Consonance Opportunity Master as the manager and member of the general partner of Consonance Opportunity Master and thereby is entitled to a portion of the profits allocation. F5: (Continued from footnote 4) Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of such securities of the Issuer except to the extent of their pecuniary interest therein. |
| Class A Ordinary SharesSEC Table I · non-derivative | IndirectBy Managed Account | 128,900 |
Reported balance
After 2020-11-23 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2020-11-23 · Purchase · Acquired 128,900 · Balance 128,900 F1: Represents part of units of Consonance-HFW Acquisition Corp. (the "Issuer") purchased in the Issuer's initial public offering for $10 per unit. Each unit consists of one Class A ordinary share ("Class A Share") of the Issuer and one-third of one warrant ("Warrant"), with each whole Warrant entitling the holder to purchase one Class A Share at $11.50 per share. The Warrants will not become exercisable until the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering. The Warrants are not being reported on this Form 4 because they cannot be exercised until the satisfaction of material conditions outside the control of the Reporting Persons. F6: Consonance Capital Opportunity Fund Management LP ("Consonance Opportunity") is an indirect beneficial owner of the Class A Shares held by a certain managed account (the "Managed Account"). Consonance Opportunity is the investment adviser of the Managed Account and exercises voting and investment power over the securities of the Issuer held by the Managed Account. Capman is the general partner of Consonance Opportunity. Consonance Opportunity receives an asset-based fee, but has no pecuniary interest. Mitchell Blutt is the manager and member of Capman. Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of such securities of the Issuer except to the extent of their pecuniary interest therein. |
| Class A Ordinary SharesSEC Table I · non-derivative | IndirectBy Consonance Life Sciences, LLC | 434,000 |
Reported balance
Holding disclosure · report date 2020-11-23 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 434,000 F7: Consonance Life Sciences, LLC ("Consonance Life Sciences") is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion over the securities held by Consonance Life Sciences and may be deemed to have shared beneficial ownership of such securities. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the securities held by Consonance Life Sciences except to the extent of their pecuniary interest therein. The Master Fund, Consonance Opportunity Master and the Managed Account in the aggregate own the majority of the unit interests in Consonance Life Sciences. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents part of units of Consonance-HFW Acquisition Corp. (the "Issuer") purchased in the Issuer's initial public offering for $10 per unit. Each unit consists of one Class A ordinary share ("Class A Share") of the Issuer and one-third of one warrant ("Warrant"), with each whole Warrant entitling the holder to purchase one Class A Share at $11.50 per share. The Warrants will not become exercisable until the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering. The Warrants are not being reported on this Form 4 because they cannot be exercised until the satisfaction of material conditions outside the control of the Reporting Persons.
F2: Consonance Capital Management LP ("Consonance Management") is an indirect beneficial owner of the Class A Shares held by Consonance Capital Master Account, LP (the "Master Account"). Consonance Management is the investment adviser of the Master Account, and pursuant to an investment advisory agreement, Consonance Management exercises voting and investment power over the securities of the Issuer held by the Master Account. Consonance Capman GP LLC ("Capman") is the general partner of Consonance Management. Consonance Management receives an asset-based fee, but has no pecuniary interest. Mitchell Blutt is the manager and member of Capman and has a pecuniary interest in the shares held by the Master Account as the manager and member of the general partner of the Master Account and thereby is entitled to a portion of the profits allocation.
F3: (Continued from footnote 2) Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of such securities of the Issuer except to the extent of their pecuniary interest therein.
F4: Consonance Management is an indirect beneficial owner of the Class A Shares held by Consonance Capital Opportunity Master Fund, LP ("Consonance Opportunity Master"). Consonance Management is the investment adviser of Consonance Opportunity Master, and pursuant to an investment advisory agreement, Consonance Management exercises voting and investment power over the securities of the Issuer held by Consonance Opportunity Master. Capman is the general partner of Consonance Management. Consonance Management receives an asset-based fee, but has no pecuniary interest. Mitchell Blutt is the manager and member of Capman and has a pecuniary interest in the shares held by Consonance Opportunity Master as the manager and member of the general partner of Consonance Opportunity Master and thereby is entitled to a portion of the profits allocation.
F5: (Continued from footnote 4) Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of such securities of the Issuer except to the extent of their pecuniary interest therein.
F6: Consonance Capital Opportunity Fund Management LP ("Consonance Opportunity") is an indirect beneficial owner of the Class A Shares held by a certain managed account (the "Managed Account"). Consonance Opportunity is the investment adviser of the Managed Account and exercises voting and investment power over the securities of the Issuer held by the Managed Account. Capman is the general partner of Consonance Opportunity. Consonance Opportunity receives an asset-based fee, but has no pecuniary interest. Mitchell Blutt is the manager and member of Capman. Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of such securities of the Issuer except to the extent of their pecuniary interest therein.
F7: Consonance Life Sciences, LLC ("Consonance Life Sciences") is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion over the securities held by Consonance Life Sciences and may be deemed to have shared beneficial ownership of such securities. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the securities held by Consonance Life Sciences except to the extent of their pecuniary interest therein. The Master Fund, Consonance Opportunity Master and the Managed Account in the aggregate own the majority of the unit interests in Consonance Life Sciences.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 23, 2020 Filed Dec 4, 2020 21:28 UTC | Surrozen, Inc./DE CHFW · Entity 6092 | PurchaseClass A Ordinary Shares | 128,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-032813 · doc4.xml · nonDerivative · entry 3 BLUTT MITCHELL J MD · CIK 0001097955 · Director · 10% owner Consonance Capital Management LP · CIK 0001544773 · Director · 10% owner Consonance Capital Opportunity Fund Management LP · CIK 0001834998 · Director · 10% owner Consonance Capman GP, LLC · CIK 0001620428 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Account Disclosed balance after: 128,900 F1 · price: Represents part of units of Consonance-HFW Acquisition Corp. (the "Issuer") purchased in the Issuer's initial public offering for $10 per unit. Each unit consists of one Class A ordinary share ("Class A Share") of the Issuer and one-third of one warrant ("Warrant"), with each whole Warrant entitling the holder to purchase one Class A Share at $11.50 per share. The Warrants will not become exercisable until the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering. The Warrants are not being reported on this Form 4 because they cannot be exercised until the satisfaction of material conditions outside the control of the Reporting Persons. F6 · ownership.nature: Consonance Capital Opportunity Fund Management LP ("Consonance Opportunity") is an indirect beneficial owner of the Class A Shares held by a certain managed account (the "Managed Account"). Consonance Opportunity is the investment adviser of the Managed Account and exercises voting and investment power over the securities of the Issuer held by the Managed Account. Capman is the general partner of Consonance Opportunity. Consonance Opportunity receives an asset-based fee, but has no pecuniary interest. Mitchell Blutt is the manager and member of Capman. Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of such securities of the Issuer except to the extent of their pecuniary interest therein. Read SEC document |
| November 23, 2020 Filed Dec 4, 2020 21:28 UTC | Surrozen, Inc./DE CHFW · Entity 6092 | PurchaseClass A Ordinary Shares | 371,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-032813 · doc4.xml · nonDerivative · entry 2 BLUTT MITCHELL J MD · CIK 0001097955 · Director · 10% owner Consonance Capital Management LP · CIK 0001544773 · Director · 10% owner Consonance Capital Opportunity Fund Management LP · CIK 0001834998 · Director · 10% owner Consonance Capman GP, LLC · CIK 0001620428 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Consonance Capital Opportunity Master Fund, LP Disclosed balance after: 371,100 F1 · price: Represents part of units of Consonance-HFW Acquisition Corp. (the "Issuer") purchased in the Issuer's initial public offering for $10 per unit. Each unit consists of one Class A ordinary share ("Class A Share") of the Issuer and one-third of one warrant ("Warrant"), with each whole Warrant entitling the holder to purchase one Class A Share at $11.50 per share. The Warrants will not become exercisable until the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering. The Warrants are not being reported on this Form 4 because they cannot be exercised until the satisfaction of material conditions outside the control of the Reporting Persons. F4 · ownership.nature: Consonance Management is an indirect beneficial owner of the Class A Shares held by Consonance Capital Opportunity Master Fund, LP ("Consonance Opportunity Master"). Consonance Management is the investment adviser of Consonance Opportunity Master, and pursuant to an investment advisory agreement, Consonance Management exercises voting and investment power over the securities of the Issuer held by Consonance Opportunity Master. Capman is the general partner of Consonance Management. Consonance Management receives an asset-based fee, but has no pecuniary interest. Mitchell Blutt is the manager and member of Capman and has a pecuniary interest in the shares held by Consonance Opportunity Master as the manager and member of the general partner of Consonance Opportunity Master and thereby is entitled to a portion of the profits allocation. F5 · ownership.nature: (Continued from footnote 4) Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of such securities of the Issuer except to the extent of their pecuniary interest therein. Read SEC document |
| November 23, 2020 Filed Dec 4, 2020 21:28 UTC | Surrozen, Inc./DE CHFW · Entity 6092 | PurchaseClass A Ordinary Shares | 500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-032813 · doc4.xml · nonDerivative · entry 1 BLUTT MITCHELL J MD · CIK 0001097955 · Director · 10% owner Consonance Capital Management LP · CIK 0001544773 · Director · 10% owner Consonance Capital Opportunity Fund Management LP · CIK 0001834998 · Director · 10% owner Consonance Capman GP, LLC · CIK 0001620428 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Consonance Capital Master Account, LP Disclosed balance after: 500,000 F1 · price: Represents part of units of Consonance-HFW Acquisition Corp. (the "Issuer") purchased in the Issuer's initial public offering for $10 per unit. Each unit consists of one Class A ordinary share ("Class A Share") of the Issuer and one-third of one warrant ("Warrant"), with each whole Warrant entitling the holder to purchase one Class A Share at $11.50 per share. The Warrants will not become exercisable until the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering. The Warrants are not being reported on this Form 4 because they cannot be exercised until the satisfaction of material conditions outside the control of the Reporting Persons. F2 · ownership.nature: Consonance Capital Management LP ("Consonance Management") is an indirect beneficial owner of the Class A Shares held by Consonance Capital Master Account, LP (the "Master Account"). Consonance Management is the investment adviser of the Master Account, and pursuant to an investment advisory agreement, Consonance Management exercises voting and investment power over the securities of the Issuer held by the Master Account. Consonance Capman GP LLC ("Capman") is the general partner of Consonance Management. Consonance Management receives an asset-based fee, but has no pecuniary interest. Mitchell Blutt is the manager and member of Capman and has a pecuniary interest in the shares held by the Master Account as the manager and member of the general partner of the Master Account and thereby is entitled to a portion of the profits allocation. F3 · ownership.nature: (Continued from footnote 2) Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of such securities of the Issuer except to the extent of their pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.